EDGAR Filing Documents for 0001203944-09-000098

Form 8-K - Current report:

SEC Accession No. 0001203944-09-000098

Filing Date

2009-10-06

Accepted

2009-10-06 08:21:48

Documents

Period of Report

2009-09-29

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 5.01: Changes in Control of Registrant
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	RAPTOR PHARMACEUTICALS 8-K 100509	rappharm8k100509.htm	8-K	42455
2	EXHIBIT 99.1 PRESS RELEASE 092809	pressrelease092809.htm	EX-99	19014
3	GRAPHIC	img1.jpg	GRAPHIC	6050
4	GRAPHIC	img2.jpg	GRAPHIC	3073
5	EXHIBIT 99.2 PRESS RELEASE 093009	pressrelease093009.htm	EX-99	16866
6	EXHIBIT 99.3 PRESS RELEASE 100109	presslrelease100109.htm	EX-99	14703
	Complete submission text file	0001203944-09-000098.txt		107686

Mailing Address 9 COMMERCIAL BLVD, SUITE 200 NOVATO CA 94949

Business Address 9 COMMERCIAL BLVD, SUITE 200 NOVATO CA 94949 415-382-1390

RAPTOR PHARMACEUTICALS CORP. (Filer) CIK: 0001203944 (see all company filings)